EXUBERA MANUFACTURING DEAL SWEETENS TECH GROUP

The Tech Group has experienced a quarter of explosive growth as it ramps up production for the launch of Exubera -- Pfizer's newly-approved and much-anticipated needle-free insulin. DrugResearcher.com (http://www.drugresearcher.com/news/ng.asp?n=67660-tech-group-west-pharmaceutical-exubera-delivery-device-manufacturing)